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Sulfuretin is a natural ﬂavonoid found in the plant Rhus verniciﬂua STOKES. The plant has been tradi-
tionally used as medicinal agent for antiviral, cathartic, diaphoretic, anti-rheumatic and sedative activities in 
East Asia. In this study we isolated and identiﬁed sulfuretin from R. verniciﬂua and investigated its anti-ad-
ipogenic activity against 3T3-L1 preadipocytes cells. We evaluated the effects of sulfuretin on the adipogenic 
transcription factors like peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer-binding 
protein α (C/EBPα), fatty acid synthase (FAS), Fabp4, adiponectin and zinc ﬁngerprint protein (Zfp) 521 by 
gene expression (real-time QPCR) and Western blot analysis. Sulfuretin treatment at Day 0 and 2 showed 
signiﬁcant reduction of lipid production in 3T3-L1 cells in concentration dependent manner. Gene expression 
analysis (real-time PCR) revealed that sulfuretin inhibited the both major adipogenic factors (C/EBPα, C/
EBPβ and PPARγ) and minor adipogenic factors (sterol regulatory element-binding protein (SREBP1c), adi-
ponectin, FAS, Fabp4, Zfp423, and Ebf1). Western blot analysis showed the increased expression of β-catenin 
and suppression of PPARγ after sulfuretin treatment. Overall, sulfuretin is a natural ﬂavonoid having potent 
anti-adipogenic activity through the suppression of major adipogenic factors C/EBPα, C/EBPβ and PPARγ, 
which initiate adipogenesis.
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Obesity is emerging as a burning health problem around the 
world. Despite various treatment measures for obesity, a low 
fat diet and increased physical activity is the main treatment 
approach.1) However, Pharmacotherapy is necessary or recom-
mended for those having a body mass index (BMI) ≥30 kg/m2 
or with a BMI ≥27 kg/m2 along with the presence of two or 
more obesity-related complications like coronary heart dis-
ease, type-2 diabetes, or sleep apnea.2)
Obesity, a major risk factor for cardiovascular disease, 
high blood pressure, type-2 diabetes and carcinogenesis, is 
mainly characterized by the increased adipogenesis, which 
is contributed by increase in both the number and size of the 
adipose cells.3–6) Adipogenesis, which involves various cellu-
lar processes, gene expressions and hormones, brings changes 
in cellular morphology of pre-adipocytes and converts them 
to adipocytes which can store large amount of fat.7,8) Many 
of the transcription factors, such as peroxisome proliferator-
activated receptor γ (PPARγ), the CCA AT/enhancer-binding 
protein (C/EBP) family, sterol regulatory element-binding pro-
tein (SREBP1c), adiponectin, fatty acid synthase (FAS), zinc 
ﬁngerprint protein (Zfp423), and early B cell factor 1 (Ebf1) 
signiﬁcantly play roles in adipogenesis either directly or indi-
rectly. PPARγ, C/EBP, and SREBP-1c are important regulators 
at the initial stage of adipogenesis.9)
Rhus verniciﬂua STOKES (family: Anacardiaceae) has been 
traditionally used as medicine for antiviral, cathartic, diapho-
retic, anti-rheumatic and sedative activities in East Asia.10) In 
a study, the R. verniciﬂua extract has signiﬁcantly reduced 
body weight, total cholesterol and low density lipoprotein 
(LDL)-cholesterol level in high-fat diet mice.10) In this study, 
we isolated a ﬂavonoid compound, sulfuretin from the plant R. 
verniciﬂua and studied its anti-adipogenic activity on 3T3-L1 
cells. Different studies have already reported its biological 
activities: anti-oxidative,11) anti-rheumatic,12) antimutagenic,13) 
cell protective,14) and anti-cancer activity.15) Its anti-adipogenic 
study is reported for the ﬁrst time in this study.
EXPERIMENTAL
Materials  Aerial parts of R. verniciﬂua were bought form 
Human Herb Co., Ltd., S. Korea. The voucher specimens 
(10-022RV) were deposited in the Pharmacognosy Laboratory 
of Wonkwang University, South Korea. Silica-gel (Kieselgel 
60, 70–230 and 230–400 mesh, Merck, Darmstadt, Germany) 
and ODS-A (12 nm, S-75 µm, YMC, Kyoto, Japan) were used 
for column chromatography. Solvents including chloroform 
(CHCl3), ethanol (EtOH), methanol (MeOH), acetone, ethyl 
acetate (EtOAc), hexane, n-butanol, were purchased form 
SK chemicals (Seongnam, Korea) and were of HPLC grade. 
3T3-L1 cells were obtained from the American Type Culture 
Collection (Rockville, MD, U.S.A.). 1H-, 13C-NMR and two-
dimensional NMR (2D-NMR) were recorded on JEOL Eclipse 
500 FT-NMR spectrometer (1H-NMR, 500 MHz; 13C-NMR, 
125 MHz) using deuterated solvent (dimethyl sulfoxide 
(DMSO)-d6 containing 0.03% tetramethylsilane (TMS)). High 
resolution electrospray ionization (ESI) mass spectra were ob-
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tained on an Agilent 6120 mass spectrometer. Dexamethasone, 
1-methy-3-isobutylxanthine (IBMX), Dulbecco’s modiﬁed Ea-
gle’s medium (DMEM), insulin were purchased from Sigma 
Chemical Co. (St. Louis, MO, U.S.A.). Antibodies against 
PPARγ, β-catenin, secondary antibodies were from Santa Cruz 
Bio-technology. Trizol reagent, RT-PCR kit and primers were 
bought from Invitrogen (Carlsbad, CA, U.S.A.).
Isolation and Identiﬁcation  R. verniciﬂua leaves were 
dried and extracted with methanol by heating (40°C). The sol-
vent was removed using rotatory evaporator and the dry meth-
anol extract was suspended in water and fractionated with 
butanol. Dried butanol fraction was loaded on silica gel open 
column and eluted with gradient (CHCl3)–MeOH (100→50%) 
to obtain fractions F1 to F10. Fraction 6 was again subjected 
to column chromatography on reverse phase silica gel (Oc-
tadecylsilane (ODS) chromatography) using solvent system 
of MeOH and water (50 to 70% MeOH). A pure compound 
(orange amorphous powder) was isolated which was later iden-
tiﬁed as sulfuretin after the UV spectrum, 1H- and 13C-NMR 
study.
Ultra Performance Liquid Chromatography (UPLC) 
Analysis  The stock solution was prepared in methanol at 
a concentration of 5 mg/mL for methanol extract of R. ver-
niciﬂua and 1 mg/mL for sulfuretin. All the solutions prior 
to injection in UPLC machine were ﬁltered through 0.20 µm 
ﬁlters (polytetraﬂuoroethylene (PTFE), hydrophilic ﬁlter). 
UPLC analysis was conducted on an Agilent 1290 series LC 
system (Agilent Technologies, CA, U.S.A.), which consisted 
DEBAA03145 binary pump, DEBAF02229 diode array detec-
tor, a DEBAP03582 auto sampler. The chromatographic sig-
nals were analyzed by Agilent ChemStation software version 
1.3. Halo RP-amide column (2.7, 4.6 150 mm) with solvent 
system methanol (A) and 0.1% phosphoric acid (B) was used 
for chromatographic separation. The gradient solvent system 
was optimized as: 0–20 min, 0–100% A at a ﬂow rate of 
1 mL/min. The column temperature was maintained at 30°C 
and injection volume was 5 µL. The detection was conducted 
at 210 nm. For the calibration curve, a serial dilution of the 
stock solution of sulfuretin (1000–15.625 µg/mL) was done to 
prepare the calibration curve. Five concentrations of sulfuretin 
were analysed in triplicate for the establishment of calibration 
curves (plotting the concentrations of analyte vs. respective 
peak areas). The equation of calibration curve was used for 
the quantiﬁcation of sulfuretin in the plant R. verniciﬂua.
Cell Viability Assay  The 3T3-L1 preadipocytes were cul-
tured in 96 well plates and incubated until 100% conﬂuency. 
The cells were then treated with various concentration of 
sulfuretin (20–150 µM) for 48 h followed by the treatment with 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) solution for three hours. The formazan complex was 
dissolved with DMSO and the absorbance was measured in 
enzyme-linked immunosorbent assay (ELISA) reader.
Culture and Differentiation of 3T3-L1 Cells  3T3-L1 
pre-adipocytes were cultured in DMEM with 10% bovine 
calf serum at 37°C in a humidiﬁed atmosphere of 5% CO2. 
Two days after the 100% conﬂuency (Day 0), cell were stimu-
lated to differentiation by replacing with differentiation media 
(MDI), i.e., DMEM containing 10% fetal bovine serum (FBS), 
0.5 mM IBMX, 1 µM dexamethasone and 10 µg/mL insulin. 
After two days (Day 2), the culture media was replaced with 
DMEM containing 10% FBS and 10 µg/mL insulin. After 
that the media was changed every 2 d (Day 4, 6 and 8) with 
DMEM containing only 10% FBS. The cells were treated with 
non-toxic concentration of sulfuretin (100, 70 and 40 µM) at 
Day 0 and 2 to evaluate the anti-adipogenic activity. After the 
establishment of anti-adipogenic activity of sulfuretin, a single 
concentration (70 µM) was treated on Day −2 (two days before 
addition of differentiation media), Day 0, 2, 4, 6 and 8 to 
evaluate at which stage the treatment would show maximum 
inhibition of lipid production.
Oil Red O (ORO) Staining  At Day 10 ORO staining was 
done to determine the lipid production. Cells were washed 
twice with 1×phosphate buffered saline (PBS), ﬁxed in 10% 
formaldehyde for 30 min, and then washed with 60% isopro-
panol and then stained with the Oil Red O working solution 
(6 : 4, 0.6% ORO dye in isopropanol–water) for 30 min at 25°C 
and washed three times with water. Staining was visualized 
by bright-ﬁeld microscopy, and ORO dyes extracted from 
the cells in isopropanol were quantiﬁed at a wavelength of 
520 nm.
Protein Extraction and Western Blotting  3T3-L1 cells 
were differentiated with or without using sulfuretin (70 µM). 
Table 1. The Primer Sequence Used for Real-Time PCR
Gene name Forward primer Reverse primer
PPARγ GCGGCTGAGAAATCACGTT TCAGTGGTTCACCGCTTCTT
C/EBPα GACCATTAGCCTTGTGTGTACTGTATG TGGATCGATTGTGCTTCAAGTT
C/EBPβ CGGGGTTGTTGATGTTTTTGG CCGAAACGGAAAAGGTTCTCA
C/EBPδ ACGACGAGAGCGCCATC TCGCCGTCGCCCCAGTC
Adiponectin GATCACTGTCAGCAGGACTT TGCCTCTTCAAGTAGCTCA
FAS GGT GAC ACT CGC AGA AGA CAA TA AACAGCCTCAGAGCGACAAT
SREBP-1c GCATGCCATGGGCAAGTAC TGTTGCCATGGAGATAGCATCT
Fabp4 CTTCAAACTGGGCGTGGAA CTAGGGTTATGATGCTCTTCACCTT
Zfp423 GATCACTGTCAGCAGGACTT TGCCTCTTCAAGTAGCTCA
Ebf1 TGCTGGTCTGGAGTGAGTTGA CCACCACACCAGGGATGTG
Fig. 1. Sulfuretin
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Cells were collected at the indicated days (Day 0, 1, 3, 6 and 
8) using a cell scraper. For the cell lysis, cells were treated 
with ice-cold RIPA buffer containing 25 mM Tris–HCl (pH 
7.6), 150 mM NaCl, 1% Nonidet P-40, 1% sodium deoxycho-
late, 0.1% sodium dodecyl sulfate (SDS) and a protease inhibi-
tor cocktail (Sigma-Aldrich) for 30 min. All cell lysates were 
centrifuged at speed of 14000 rpm for 20 min at 4°C to remove 
cell debris. Then the protein concentration of each sample was 
calculated using a BCA protein assay kit (Pierce, Rockford, 
IL, U.S.A.). Cellular proteins (50 µg) were loaded and sepa-
rated by 10% SDS-polyacrylamide gel electrophoresis. After 
that the gels were transferred to nitrocellulose membranes at 
150 mA for 1 h and were blocked with PBS containing 5% 
skim milk and 0.1% Tween 20 for 2 h at room temperature. 
The blots were incubated with primary antibodies (1 : 1000 
dilutions) overnight at 4°C followed by secondary antibody for 
1 h. The protein bands were determined from the gel image 
system.
Quantitative Real-Time PCR  3T3-L1 cells were dif-
ferentiated in presence or absence of sulfuretin (70 µM). Cells 
were collected at the indicated days (Day 0, 1, 3, 6, 8 and 10) 
and lysed with 1 mL Trizol. The acquired cell lysate were 
added to chloroform and centrifuged to yield RNA fraction. 
The RNA fraction was mixed with 0.5 mL isopropyl alcohol 
and centrifuged at 12000 rpm for 10 min at 4°C for RNA 
precipitation. The precipitated RNA were washed and dried 
at room temperature for 10 min and dissolved in ribonuclease 
(RNase)-free diethyl pyrocarbonate (DEPC) treated water. The 
ﬁrst strand cDNA was synthesized using a cDNA synthesis 
kit (Clontech Advantage® RT-for-PCR kit, #639506). The gene 
expression levels were analysed by quantitative real-time PCR 
using AB 7900HT Real Time PCR system (Applied Biosys-
tems #4364346, Foster City, CA, U.S.A.). The primers used in 
the experiments are shown in Table 1. After an initial incuba-
tion for 2 min at 50°C, the cDNA was denatured at 95°C for 
5 min followed by 40 cycles of PCR (95°C, 20 s, 60°C, 120 s). 
Fig. 2. UPLC Analysis of Sulfuretin and Methanol Extract of R. verniciﬂua
(A) UPLC chromatogram of sulfuretin and its UV spectrum. (B) UPLC chromatogram methanol extract of R. verniciﬂua with UV spectrum of sulfuretin corresponding 
peak.
Table 2. Quantiﬁcation Table of Sulfuretin in R. verniciﬂua from the 
Calibration Curve
Analyte Regression  equation
Correlation 
coefﬁcient
Quantity  
(mg/g of plant)
Sulfuretin y=18009x+280.02 0.9966 1.22
Fig. 3. Cell Viability of Different Concentrations of Sulfuretin in 
3T3-L1 Preadipocytes Cells after MTT Assay
The results represent the means±S.D. of the data in triplicated experiments. 
* p<0.05, vs. differentiated control cells.
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Fig. 4. Sulfuretin Inhibits the Differentiation of 3T3-L1 Preadipocytes
A: Scheme for the differentiation of 3T3-L1 cells. B: 3T3-L1 cells were induced to differentiate in the presence or absence of various concentrations of sulfuretin (40, 
70, and 100, 70 µM). After 10 d, the cells were stained with ‘oil red O’ and photographed. C: Oil red O staining was quantitatively analyzed. Data represent the mean value 
(± S.D.) of three independent experiments. ** indicates signiﬁcance difference p<0.05 and p<0.001, respectively compared with the control.
Fig. 5. Sulfuretin Suppressed the Initiation of Adipocyte Differentiation
A: 3T3-L1 preadipocytes were incubated with 70 µM of sulfuretin along with differentiating media. Sulfuretin was treated at the different time during the period of dif-
ferentiation. The thick line indicates the time of sulfuretin treatment. B: 3T3-L1 cells were differentiated for 10 d and were ﬁxed in 10% formaldehyde and stained with 
oil red O and photographed. Sulfuretin was highly potent when treatment was done at Day 0 and 2. Treatment before addition of MDI (Day −2) and at the later stage of 
differentiation (Day 4, 6 and 8) showed no signiﬁcant activity.
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All results were obtained from at least three independent ex-
periments. The mRNA levels of all genes were normalized 
using cyclophilin as internal control.
RESULTS AND DISCUSSION
Structure Identiﬁcation of Isolated Compound  The 
1H-NMR, 13C-NMR, mass and UV-visible absorption maxi-
mum (λmax) data of the isolated compound were taken for the 
structure elucidation. The data as given below were compared 
with the published literatures and the compound was con-
ﬁrmed to be sulfuretin11,16,17) (Fig. 1).
Orange coloured powder, C15H10O5, MW 270. Electrospray 
ionization (ESI)-MS m/z (negative) 269.10 [M−H]−; 1H-NMR 
(500 MHz, DMSO-d6) δ: 6.64 (1H, s, H-2), 6.70 (1H, dd, 
J=1.85, 8.25 Hz, H-6), 6.74 (1H, d, J=1.85 Hz, H-8), 6.83 
(1H, d, J=8.25 Hz, H-5′), 7.24 (1H, dd, J=2.3, 8.2 Hz, H-6′), 
7.44 (1H, d, J=1.85 Hz, H-2′), 7.60 (1H, d, J=8.7 Hz, H-5); 
13C-NMR (125 MHz, DMSO-d6) δ: 112.3 (C-2), 146.2 (C-3), 
148.6 (C-4), 126.3 (C-5), 125.1 (C-6), 168.0 (C-7), 98.9 (C-8), 
166.7 (C-9), 113.8 (C-10), 123.9 (C-1′), 118.5 (C-2′), 146.1 
(C-3′), 148.6 (C-4′), 116.6 (C-5′), 125.1 (C-6′). UV/V λmax 
(MeOH): 206, 210, 394 nm.
UPLC Analysis  The UPLC analysis was used for the 
quantiﬁcation of the sulfuretin in the plant R. verniciﬂua. The 
retention time of isolated compound and its UV spectrum was 
evaluated for the identiﬁcation of sulfuretin peak in the chro-
matogram of methanol extract of R. verniciﬂua. The UPLC 
chromatograms of sulfuretin and plant extract (Fig. 2) reveal 
sulfuretin peak at retention time of approximately 10.35 min. 
The chromatograms were detected at 210 nm wavelength. The 
linearity of the calibration curve was satisfactory (R2=0.996). 
The quantiﬁcation of sulfuretin in the R. verniciﬂua was ob-
tained from the regression equation of the calibration curve 
and peak area of sulfuretin in the extract. The R. verniciﬂua 
contains around 0.122% of sulfuretin (Table 2).
Cell Viability  Different concentrations of sulfuretin 
(20–150 µM) were taken for the viability test against 3T3-L1 
cells using MTT assay. The results of viability test (Fig. 3), 
show that up to 100 µM of sulfuretin was safe (nearly 90% vi-
ability) for the 3T3-cell experiment.
Effect of Sulfuretin in the Accumulation of Lipid Drop-
Fig. 6. Effect of mRNA Expression of Different Proteins during Adipogenesis with or without Sulfuretin (70 µM) Treatment
A, B, C, D: Real time PCR showing the levels of C/EBPδ, C/EBPβ, C/EBPα, and PPARγ, respectively at the indicated days in 3T3-L1 with or without sulfuretin treat-
ment. E: Western-blot analysis for expression of β-catenin and PPARγ in the cellular extracts of differentiated cells with or without sulfuretin treatment. Data represent the 
mean value (±S.D.) of three independent experiments. * and ** indicate signiﬁcance difference p<0.05 and p<0.001, respectively compared with the control.
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lets in 3T3-L1  3T3-L1 preadipocytes cell were differenti-
ated with or without the presence of sulfuretin (100, 70 and 
40 µM) as indicated in Fig. 4A. At Day 10 the lipid production 
was evaluated and quantiﬁed by ORO staining technique. The 
lipid droplets (red) as shown in Fig. 4B captured in micro-
scope reveal that sulfuretin strongly inhibited the lipid pro-
duction. The lipid production was reduced by approximately 
65% at 70 and 100 µM (Fig. 4C). It conﬁrmed that sulfuretin 
inhibits lipid production in 3T3-L1 cells signiﬁcantly when 
treated at Day 0 and 2.
We also tried to ﬁnd out the anti-adipogenic effect of sul-
furetin, when treated before the beginning of differentiation 
(Day −2) and at the later part of differentiation (Day 4, 6 and 
8) as indicated in Fig. 5A. The ORO results (Fig. 5B) revealed 
that sulfuretin treatment at Day 0 and 2 only had signiﬁcant 
inhibition on adipogenesis. There was no effect of sulfuretin 
when the treatment was at Day −2, i.e., two days before the 
treatment of differentiation media. Similarly sulfuretin treat-
ment after some days of introducing differentiation media 
(Day 4, 6 and 8) had also no good results in the inhibition of 
lipid production. Sulfuretin was found to be most effective 
when the treatment was done at Day 0 and 2. From these ob-
Fig. 7. Real Time PCR Showing the Levels of SREBP 1c, FAS, Adiponectin, Fabp4, Zfp423 and Ebf1 at the Indicated Days in 3T3-L1 Cells during 
Adipogenesis in the Presence or Absence of Sulfuretin (70 µM)
The level of the factors decreased after the sulfuretin treatment. Data represent the mean value (±S.D.) of three independent experiments. * and ** indicate signiﬁcance 
difference p<0.05 and p<0.001, respectively compared with the control.
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servations we can understand that sulfuretin inhibits the mas-
ter adipogenic factors which initiate the adipogenesis. Once 
the adipogenesis is started, then the role of sulfuretin in lipid 
inhibition is rapidly diminished.
Effect of Sulfuretin on mRNA Levels of PPARγ, CCAAT/
Enhancer Binding Protein (C/EBP), and β-Catenin  From 
several studies it has been established that C/EBPβ and C/
EBPδ are the ﬁrst transcription factors induced after exposure 
of MDI to the 3T3-L1 preadipocytes.18) Different study has 
provided the correlation of induction of PPARγ and C/EBPα 
during adipogenesis by C/EBPβ and C/EBPδ activity.19,20) The 
activity of C/EBPβ and C/EBPδ is thought to mediate the 
expression of PPARγ, which is transcriptionally induced two 
days after induction of differentiation and remain maximum 
from Day 6 to 8.21,22) In our study also (Figs. 6A–E) we saw 
similar pattern in the level of all the three adipogenic factors 
in the control during the adipogenesis. When sulfuretin was 
treated along with MDI (Day 0), we saw decrease in expres-
sion of C/EBPβ and C/EBPδ, the early transcription factors 
of adipogenesis. The expression of PPARγ and C/EBPα also 
decreased after sulfuretin treatment. These results suggest 
that sulfuretin blocked the expression of C/EBPβ and C/EBPδ 
which in turn inhibited the expression of PPARγ and C/EBPα. 
This illustrates that sulfuretin suppresses the early program 
of adipogenesis by inhibiting C/EBPβ and C/EBPδ. The ORO 
results also support this ﬁnding as there was greater inhibition 
of lipid production in early treatment of sulfuretin (Fig. 5B).
It has been well established that Wnt signalling is a nega-
tive regulator of adipogenesis in vitro and in vivo by inter-
fering the induction of PPARγ and C/EBPα.23) Thus, we hy-
pothesized that sulfuretin may inhibit the adipogenesis, also 
through the activation of Wnt pathways. To test that, we mea-
sured β-catenin protein levels as the readout for the activity 
of canonical Wnt signalling. From the Western blot data (Fig. 
6E) we found that β-catenin levels were signiﬁcantly increased 
with sulfuretin treatment. So, the activation of β-catenin by 
sulfuretin also medicated the suppression of PPARγ.
Effect of Sulfuretin on Expression of SREBP-1c, Adipo-
nectin, FAS, Fabp4, Zfp423, and Ebf1  Our next investi-
gation was to see how sulfuretin brings changes in the level 
of other regulators of adipogenesis. SREBP-1c, adiponectin, 
FAS, Fabp4, Zfp423 and Ebf1 are the important regulators of 
production, transport and storage of lipid. All these factors 
have important role in lipid production and accumulation in 
3T3-L1 cells. The role of SREBP-1c is to stimulate transcrip-
tion of genes which involve in fatty acid synthesis.24) The 
enzyme FAS is a key enzyme of lipogenesis which catalyses 
all the reactions that produce palmitic acid from acetyl-CoA 
and malonyl-CoA.25) During the time of lipogenesis, its activ-
ity gets triggered.26) Adiponectin is another important protein 
for cell proliferation and differentiation from preadipocytes 
to adipocytes and play vital role in increasing lipid content in 
adipocytes.27) FABP4 is known to regulate intracellular fatty 
acid and lipid metabolisms.28) Ebf1 induces the expression of 
PPARγ and C/EBPα and Zfp423 promotes adipose linage com-
mitment.29,30) We checked the level of expression of mRNAs of 
SREBP-1c, adiponectin, FAS, Fabp4, Zfp423 and Ebf1 using 
QPCR in the differentiated adipocytes with or without the 
treatment of sulfuretin at Day 0. The regulators were found to 
be highly expressed during adipogenesis (control group) and 
when sulfuretin was treated along with MDI, levels of mRNA 
expression of those regulators were decreased (Fig. 7). So, our 
data suggest that sulfuretin suppressed the expression of other 
regulators involved in lipid transportation and storage.
CONCLUSION
It is well accepted that the excessive synthesis and accu-
mulation of lipid in the adipocyte cells leads to the occur-
rence of obesity.31) To treat obesity, the exploration of natural 
products as alternative medicine is increasing.32) This study is 
an endeavour to ﬁnd and establish anti-adipogenic activity of 
sulfuretin. It inhibited the 3T3-L1 proliferation in a dose and 
time dependent manner by inhibiting early adipogenic factors 
like C/EBPβ and C/EBPδ along with β-catenin. Sulfuretin is a 
major constituent of the plant, R. verniciﬂua, which anti-adip-
ogenic activity has already been reported. So, we can estimate 
that the anti-adipogenic activity of R. verniciﬂua might be due 
to sulfuretin. Overall, sulfuretin is a potent anti-adipogenic 
phytochemical and can be a potential pharmaceutical ingredi-
ent for obesity treatment. So, a further study on this ﬂavonoid 
is necessary.
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